SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced it will be presenting a poster this Sunday in Chicago at the American College of Rheumatology (ACR) Convergence 2025 meeting. Nkarta will present clinical data showing that the company’s investigational therapy, NKX019, achieved robust pathogenic B-cell depletion followed by ...

According to Schneider Electric’s latest report, the EU currently spends €380 billion annually on energy imports, with nearly 60% of its energy supply sourced from abroad.Accelerated electrification and prosumer initiatives could create up to 1 million new jobs in local industries.The EU’s rooftop solar potential is estimated at over 1,000 GW, 10 times the current installed capacity. Electrification Asset.jpg Electrification Asset.jpg Copenhagen, Denmark, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Schneider Elect ...

Core Insights - BioRestorative Therapies, Inc. has appointed Crystal Romano to lead its global commercial operations and innovation, marking a significant step in the company's growth strategy [1][3] Company Overview - BioRestorative is focused on regenerative medicine, particularly stem cell-based therapies and products, with two main clinical development programs targeting disc/spine disease and metabolic disorders [4] - The company also operates a commercial BioCosmeceutical platform, developing products that utilize cell-based secretome containing exosomes, proteins, and growth factors [6][7] Leadership and Strategy - Crystal Romano brings over 19 years of experience in the medical and regenerative industries, recognized for her expertise in product development, commercialization, and navigating FDA regulations [2] - The CEO of BioRestorative emphasized the importance of Romano's role at a critical time for the company, aiming to expand its commercial footprint and unlock revenue opportunities [3] Clinical Development Programs - The Disc/Spine Program includes BRTX-100, a cell therapy candidate derived from a patient's own mesenchymal stem cells, currently in Phase 2 clinical trials for chronic lower back pain [4] - The Metabolic Program, ThermoStem, focuses on using brown adipose-derived stem cells to target obesity and metabolic disorders, with promising preclinical research indicating potential benefits for weight loss and metabolic health [5] Future Directions - BioRestorative aims to expand its BioCosmeceutical offerings through IND-enabling studies, seeking to pioneer FDA approvals in the emerging market [7]

Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026. These offerings complement the availability of the company’s existing and marketing-leading global fertility ...

AGOURA HILLS, CALIFORNIA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- On October 21, 2025, 40 Brightwater LLC executed Sales Purchase Agreement for $10,000,000,000 (ten billion USD) worth of Bitcoin (BTC) at a 90% Discount / 90% Premium which will allow plenty of leverage with PEG Global Private Equity X S.A.SICAV-RAIF's Cryptocurrency Lender. 40 Brightwater LLC also executed a Letter of Intent (LOI) on October 9, 2025 with PEG Global Private Equity X S.A.SICAV-RAIF for a 10-year loan in the amount $21,000,000,000 (t ...

Core Viewpoint - Diana Shipping Inc. has extended time charter contracts for two of its dry bulk vessels, the m/v Semirio and the m/v Maera, which are expected to generate significant revenue for the company [1][3][4]. Group 1: Charter Contracts - The time charter contract for the m/v Semirio has been extended with Solebay Shipping Cape Company Limited at a gross charter rate of US$21,650 per day, effective from March 15, 2026, until a minimum of January 31, 2027, and a maximum of April 15, 2027 [1]. - The m/v Semirio is currently chartered at a gross rate of US$16,650 per day [1]. - The m/v Maera has entered into a time charter contract with CRC Shipping Pte. Ltd. at a gross charter rate of US$11,750 per day, expected to commence on November 2, 2025, and lasting until a minimum of October 20, 2026, and a maximum of December 20, 2026 [3]. Group 2: Revenue Generation - The employments of the m/v Semirio and m/v Maera are anticipated to generate approximately US$10.93 million in gross revenue for the minimum scheduled period of the time charters [4]. Group 3: Fleet Overview - Diana Shipping Inc. currently operates a fleet of 36 dry bulk vessels, including various types such as Newcastlemax, Capesize, Post-Panamax, Kamsarmax, Panamax, and Ultramax [5]. - The combined carrying capacity of the fleet, excluding two vessels not yet delivered, is approximately 4.1 million dwt, with a weighted average age of 11.91 years [5]. - The company expects to take delivery of two methanol dual fuel new-building Kamsarmax dry bulk vessels by the second half of 2027 and the first half of 2028 [5]. Group 4: Company Profile - Diana Shipping Inc. is a global provider of shipping transportation services, specializing in the ownership and bareboat charter-in of dry bulk vessels, primarily engaged in short to medium-term time charters [6].

Geneva, Switzerland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES), a global leader in semiconductors and Post-Quantum Cryptography (PQC) solutions, today unveiled the Quantum Shield QS7001, the first secure chip to embed NIST-standardized PQC algorithms directly at the hardware level. The chip will be officially launched in mid-November 2025, following its debut at the IQT Quantum+AI 2025 Conference in New York City, where SEALSQ’s CEO, Carlos Moreira, presented it during his keynote “AI Mee ...

Miami, FL, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (OTCQB: ONAR), a leading network of marketing and technology companies, announced today that Retina, its recently acquired AI-powered marketing intelligence platform, is on track to launch a commercially ready new product within 30 days. As part of this milestone, ONAR has appointed Brad Ito, former Chief Technology Officer of Retina, as Interim CTO of ONAR to oversee the platform’s reintroduction and broader integration across ONAR’s por ...

DENVER, Oct. 22, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that southern rock legends The Marshall Tucker Band will headline an exclusive private performance following VENU’s (NYSE American: VENU), a growing operator of premium hospitality and live entertainment venues across the U.S., 2025 Annual Meeting of Shareholders, set for Tuesday, October 28, 2025, at VENU’s Phil Long Music Ha ...

CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties with the ability to ask questions and submit topics for future videos Access the Akari CEO Corner here BOSTON and LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the launch of its CEO Corner featuring Abizer Gaslightwala, Preside ...